This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RAT ANTI MOUSE CD8:Preservative Free
catalog :
MCA1768XZ
quantity :
1 mg
price :
598 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
YTS169.4
reactivity :
mouse
application :
flow cytometry
citations: 2
Published Application/Species/Sample/DilutionReference
  • flow cytometry; mouse; loading ...; fig 3a
Sorrentino C, Ciummo S, D Antonio L, Lanuti P, Abrams S, Yin Z, et al. Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signaling. Clin Transl Med. 2021;11:e278 pubmed publisher
Benencia F, Courreges M, Coukos G. Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. J Transl Med. 2008;6:21 pubmed publisher
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA1768XZ
Description :
RAT ANTI MOUSE CD8:Preservative Free
Specificity :
CD8
TargetSpecies :
Mouse
Host :
Rat
Format :
Preservative Free
Isotypes :
IgG2b
Applications :
F,C
ApplicationTypes :
Flow Cytometry,Immunohistology - Frozen
Clone :
YTS169.4
Quantity :
1 mg
QuantityValue :
1
QuantityType :
mg
GOAccessions :
GO:0016021,GO:0002456,GO:0045065,GO:0042803,GO:0009897,GO:0007166,GO:0009897,GO:0016021,GO:0005515,GO:0050850
GOTerms :
alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,transmembrane,juxtamembrane,outer surface of cytoplasmic membrane,cell-mediated immunity,cellular immune response,T lymphocyte mediated immunity,T-cell mediated immunity,T-lymphocyte mediated immunity,transmembrane,cell surface receptor linked signal transduction,cell surface receptor linked signalling pathway,juxtamembrane,outer surface of cytoplasmic membrane,dimerization activity,cytotoxic T cell development,cytotoxic T lymphocyte selection,cytotoxic T-cell selection,cytotoxic T-lymphocyte selection,activation of calcium-mediated signaling,positive regulation of calcium-mediated signalling,stimulation of calcium-mediated signaling,up regulation of calcium-mediated signaling,up-regulation of calcium-mediated signaling,upregulation of calcium-mediated signaling
UniprotAccessions :
P10300,P01731
Gene :
Cd8a,Cd8b1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=12525, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=12526
EntityFormats :
ALEXA FLUOR® 405,ALEXA FLUOR® 647,FITC,Preservative Free,Purified,RPE
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
ProductForm :
Purified IgG - liquid
PriceGBP :
427
PriceEUR :
598
PriceUSD :
598 USD
PriceCHF :
651.82
PriceSEK :
6285
PriceNOK :
6405
PriceDKK :
4461
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.